New 'binding-to-release' method targets cancer drugs with precision

Researchers at the University of Oxford developed a novel drug delivery system that precisely targets cancer cells. The strategy involves a 'binding-to-release' mechanism, allowing drugs to be administered in an inactive form and only activated upon reaching the tumor. This aims to reduce side effects and improve treatment efficacy.